| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2015 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144-3448 | RENSSELAER | USA | R41ES026250 | Mass Spectrometric Screening of the Effect of Chemical Toxicants on the Human Epitranscriptome during Stem Cell Differentiation | 000 | 1 | NIH | 1/28/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2015 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144-3452 | RENSSELAER | USA | R41ES026224 | The Development of a High-Throughput Assay to Screen Chemical Compounds in Human Pluripotent Stem Cell Derived Neural Cells | 000 | 1 | NIH | 7/19/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = -$18,083 ) |
| | 2017 | 2015 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144-3452 | RENSSELAER | USA | R41ES026250 | Mass Spectrometric Screening of the Effect of Chemical Toxicants on the Human Epitranscriptome during Stem Cell Differentiation | 000 | 1 | NIH | 7/17/2017 | $0 |
| | 2017 | 2015 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144-3452 | RENSSELAER | USA | R41ES026224 | The Development of a High-Throughput Assay to Screen Chemical Compounds in Human Pluripotent Stem Cell Derived Neural Cells | 000 | 1 | NIH | 7/17/2017 | $0 |
| | 2017 | 2014 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144-3452 | RENSSELAER | USA | R41DA038983 | Modified RNA tools and diagnostics for drug abuse | 000 | 1 | NIH | 2/23/2017 | -$18,083 |
|
| Issue Date FY: 2015 ( Subtotal = $446,157 ) |
| | 2015 | 2015 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144 | RENSSELAER | USA | R41ES026250 | Mass Spectrometric Screening of the Effect of Chemical Toxicants on the Human Epitranscriptome during Stem Cell Differentiation | 000 | 1 | NIH | 8/21/2015 | $224,437 |
| | 2015 | 2015 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144 | RENSSELAER | USA | R41ES026224 | The Development of a High-Throughput Assay to Screen Chemical Compounds in Human Pluripotent Stem Cell Derived Neural Cells | 000 | 1 | NIH | 8/24/2015 | $221,720 |
|
| Issue Date FY: 2014 ( Subtotal = $224,975 ) |
| | 2014 | 2014 | ATHGHIN BIOTECHNOLOGY INC | ONE DISCOVERY DR | RENSSELAER | NY | 12144 | RENSSELAER | USA | R41DA038983 | Modified RNA tools and diagnostics for drug abuse | 000 | 1 | NIH | 8/19/2014 | $224,975 |
|
|
